Ads
related to: acute myeloid leukemia treatment- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Search results
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 15 hours agoMartin Tallman. Dr. Tallman is an internationally renowned clinical investigator whose discoveries have fueled the progress of leukemia-targeting therapies, most recently ...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 6 days agoAfter re-manufacturing the lentivirus, Hemogenyx successfully addressed the FDA's concerns and...
Senti Biosciences reports breakthrough in AML treatment By Investing.com
Investing.com· 1 day agoThis data, which was recently published in the journal Cell Reports, highlights the ability of...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 2 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue
Medscape· 7 days agoAre you familiar with the presentation, workup, treatment, and monitoring of CML? Dr Adam Braun provides a brief guide.
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 7 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
Cullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Growth in Short Interest
ETF DAILY NEWS· 3 days agoCullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 1,680,000 shares ...
Affimed (NASDAQ:AFMD) Short Interest Update
ETF DAILY NEWS· 3 days agoAffimed (NASDAQ:AFMD – Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 219,400 shares, an increase ...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 2 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Ads
related to: acute myeloid leukemia treatment